Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing
– Mekonos’ silicon nanoneedle-based delivery platform will provide Accelerated Bio with high efficiency, high viability cell engineering – including the precise and gentle delivery of multiplexed genetic cargo into its pluripotent hTSCs
– Accelerated Bio’s ethically derived and multi-functional hTSCs offer manufacturers a scalable and robust foundation for next-generation biomanufacturing
– Using Mekonos’ technology, Accelerated Bio will bypass the limitations of conventional delivery approaches like electroporation, for improved non-viral delivery into its fragile stem cells